[HTML][HTML] Decision of anticoagulation in nonvalvular atrial fibrillation in the real world in the non-antivitamin K anticoagulants era
GS Gheorghe, AS Hodorogea, ACD Gheorghe… - Healthcare, 2022 - mdpi.com
Background. Patients with nonvalvular atrial fibrillation (NVAF) have five times higher risk of
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era.
GS Gheorghe, AS Hodorogea… - Healthcare (2227 …, 2022 - search.ebscohost.com
Background. Patients with nonvalvular atrial fibrillation (NVAF) have five times higher risk of
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era.
GS Gheorghe, AS Hodorogea… - Healthcare (Basel …, 2022 - europepmc.org
Background. Patients with nonvalvular atrial fibrillation (NVAF) have five times higher risk of
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
[PDF][PDF] Trus, ca, EC; Eden, O.; et al. Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era …
GS Gheorghe, AS Hodorogea, ACD Gheorghe… - 2022 - pdfs.semanticscholar.org
Background. Patients with nonvalvular atrial fibrillation (NVAF) have five times higher risk of
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era
GS Gheorghe, AS Hodorogea… - Healthcare (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
Background. Patients with nonvalvular atrial fibrillation (NVAF) have five times higher risk of
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
[HTML][HTML] Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era
GS Gheorghe, AS Hodorogea, ACD Gheorghe… - Healthcare, 2022 - ncbi.nlm.nih.gov
Background. Patients with nonvalvular atrial fibrillation (NVAF) have five times higher risk of
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era
GS Gheorghe, AS Hodorogea, ACD Gheorghe… - …, 2022 - search.proquest.com
Background. Patients with nonvalvular atrial fibrillation (NVAF) have five times higher risk of
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …